3-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one

ID: ALA5207934

PubChem CID: 51353352

Max Phase: Preclinical

Molecular Formula: C23H19FN2O4S

Molecular Weight: 438.48

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)/C=C/c2c(-c3ccc(F)cc3)nc3sccn23)cc(OC)c1OC

Standard InChI:  InChI=1S/C23H19FN2O4S/c1-28-19-12-15(13-20(29-2)22(19)30-3)18(27)9-8-17-21(14-4-6-16(24)7-5-14)25-23-26(17)10-11-31-23/h4-13H,1-3H3/b9-8+

Standard InChI Key:  PTOJCMAWQFZHOM-CMDGGOBGSA-N

Molfile:  

 
     RDKit          2D

 31 34  0  0  0  0  0  0  0  0999 V2000
    1.5995   -0.7888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4245   -0.7888    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6747   -1.5927    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0211   -2.0635    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3537   -1.5715    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1322   -0.3013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.7890   -0.7955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5119   -1.5950    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.5526   -1.7862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1849   -0.0706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3555   -0.0706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0590    0.6475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8884    0.6475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3555    1.3658    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3033   -0.0705    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1302   -0.0697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5449    0.6486    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1337    1.3641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3048    1.3689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3377   -2.5873    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4610   -2.8005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0476   -2.2139    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8356   -1.4164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0363   -1.1973    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5448   -0.7879    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3741   -0.7879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3743    0.6486    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7890    1.3668    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5484    2.0823    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1337    2.8005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8487   -2.4286    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  1  5  2  0
  5  4  1  0
  2  6  1  0
  6  7  2  0
  8  7  1  0
  3  8  1  0
  5  9  1  0
  1 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  1  0
 12 14  2  0
 15 13  2  0
 16 15  1  0
 17 16  2  0
 18 17  1  0
 19 18  2  0
 13 19  1  0
 20  9  2  0
 21 20  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
  9 24  1  0
 16 25  1  0
 25 26  1  0
 17 27  1  0
 27 28  1  0
 18 29  1  0
 29 30  1  0
 22 31  1  0
M  END

Associated Targets(Human)

IGROV-1 (47897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAKI-1 (44928 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.48Molecular Weight (Monoisotopic): 438.1050AlogP: 5.12#Rotatable Bonds: 7
Polar Surface Area: 62.06Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 3.40CX LogP: 4.33CX LogD: 4.33
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.30Np Likeness Score: -1.21

References

1. Sbenati RM, Semreen MH, Semreen AM, Shehata MK, Alsaghir FM, El-Gamal MI..  (2021)  Evaluation of imidazo[2,1-b]thiazole-based anticancer agents in one decade (2011-2020): Current status and future prospects.,  29  [PMID:33316752] [10.1016/j.bmc.2020.115897]

Source